Investment in Cancer Research in 2022
Today, the CCRA released its latest report on the investment in cancer research from 2005 to 2022, with a focus on the period 2020-2022 to examine the potential impact of COVID-19. There was $526M invested in cancer research in 2022. The overall cancer research investment was fairly flat from 2019-2022, although the number of new and in-progress projects continued to decline. Research investment in breast, prostate and blood cancers declined from 2020 on and investment in operating grants fell steeply from 2020, particularly investments offered through national priority-driven competitions. Strategies employed by cancer research funders to mitigate the impacts of the pandemic on cancer research funding are described. This report has an accompanying Excel file as well as dashboard tools that expand on the findings in the report. To access this report, click here.
Are You the Next Scientific Director of CIHR’s Institute of Cancer Research?
As you know, the CIHR-ICR funds cancer research in Canada based on internationally accepted standards of excellence with the goal of reducing the burden of cancer on individuals and is dedicated to creating and maintaining a robust cancer research environment in Canada. This positi... Read More »
As you know, the CIHR-ICR funds cancer research in Canada based on internationally accepted standards of excellence with the goal of reducing the burden of cancer on individuals and is dedicated to creating and maintaining a robust cancer research environment in Canada. This positi... Read More »
Ending Cervical Cancer in Canada is Possible
The Canadian Partnership Against Cancer is calling on partners in health care and communities across Canada to end cervical cancer in Canada by 2040. The Partnership is leading the development and implementation of a Canadian plan to achieve the World Health Organization (WHO)’s ... Read More »
The Canadian Partnership Against Cancer is calling on partners in health care and communities across Canada to end cervical cancer in Canada by 2040. The Partnership is leading the development and implementation of a Canadian plan to achieve the World Health Organization (WHO)’s ... Read More »